Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A 2022 systematic review in Frontiers in Pharmacology identified 98 preclinical studies but zero controlled human pharmacokinetic trials [1]
However, the lack of a clearly defined primary molecular target and the complexity of the peptide mixture present significant challenges for mechanistic understanding and clinical translation
Research suggests it may promote angiogenesis, the formation of new blood vessels, enhancing circulation to damaged areas and supporting healing
The level of active ingredients could be higher or lower than claimed and these ingredients could interact with other medications and foods
US$ 25.77
US$ 28.22
US$ 26.21
